This is the other similarity although it could be a conincidence both are ASX 200 stocks and heavily shorted (although PNV is much higher). Both cases UBS represents a huge % of relative volume (more than 3x the broker group), both cases the middle of May there may have been a shift to net accumulate after months of net selling.
1 Month: (Biotech and Health) (500m+) sorted by net volume/shares (+ve)
1 Year: (Biotech and Health) (500m+) sorted by net volume/shares (-ve)
This is the other similarity although it could be a conincidence...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.030(2.49%) |
Mkt cap ! $811.7M | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.17 | $2.698M | 2.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4273 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 10804 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |